Unitree Prices IPO in Shanghai at $904 Million and Brings Tencent, Meituan, and DeepSeek to the Humanoid Market

Hangzhou-based Unitree Robotics, also known as Yushu Technology, priced its IPO on the STAR Market of the Shanghai Stock Exchange at 150.80 yuan per share, valuating the company at 61 billion yuan, approximately $9.04 billion, on August 6th. The company sold 40.45 million new shares, which is 10% of the enlarged capital, raising 6.1 billion yuan, roughly $904 million. Subscriptions open on August 10th, with the debut trading expected in mid-month.

The strategic book is the most interesting aspect of this operation. DeepSeek, the AI lab responsible for the R1 and V3 model families and for conflicts with American suppliers, invested 140.8 million yuan ($20.8 million) and signed an agreement to develop language models embedded in humanoid machines. Tencent and Meituan have joined the anchor allocation, a rare move in a robotics listing that signals a bet on corporate distribution channels and last-mile logistics. Unitree becomes the first humanoid-focused manufacturer listed in the Chinese domestic market.

The Product That Justifies the Valuation

Unitree currently offers three commercial lines. The quadruped Go2 is sold starting at $1,600 and has become the reference standard in university research. The humanoid H1, launched in 2023, costs starting at $90,000 and operates proprietary locomotion models with 47 degrees of freedom. The G1, more compact and priced from $16,000, is aimed at short-term industrial use and has already been purchased for pilot operations by BYD, Xiaomi, and the Chinese Guanglin Group.

The prospectus itself acknowledges limitations. The company reported revenue of 2.17 billion yuan in 2025, but a net loss of 340 million yuan, and still depends on exports to Western universities and integrators. The multiple of 28 times revenue implied in the IPO requires Unitree to scale industrial volume in the next three years, something that no humanoid manufacturer has done consistently.

The Counter-Argument Comes from the U.S. and Japan

Optimism about humanoids is not universal. "We are two hardware cycles away from anything remotely resembling a viable commercial proposition at scale," said Rodney Brooks, co-founder of iRobot, in a blog post last month. Boston Dynamics, controlled by the Hyundai group since 2021, sold only about 400 units of the industrial version of Atlas last year, at $250,000 each. Honda discontinued ASIMO in 2018, and Toyota maintains its humanoid division as pure research. Thus, what Unitree promises is an aggressive cost curve enabled by an integrated Chinese supplier chain, not a scientific advantage.

From Germany, Agility Robotics sold 800 units of Digit for Amazon's operation in Nashville and aims for 2,000 by 2026. Figure AI, based in Sunnyvale, closed a $1.5 billion funding round in February led by Microsoft and Nvidia, achieving a valuation of $39.5 billion. What Unitree's listing does is offer, for the first time, a public pricing reference for the entire segment in a jurisdiction outside the United States.

Regional Reading

In China, the IPO is celebrated as validation of the "Made in China 2025" industrial policy for advanced robotics and adds pressure on American regulators who are discussing in Washington the expansion of the Entity List to include autonomous robots with embedded AI. In South Korea, LG and Samsung are accelerating partnerships with local humanoid startups following the announcement from the Lee Jae-myung government of a $3 billion subsidy for general-purpose robotics until 2028. In Germany, the Federation of Mechanical Engineering (VDMA) already projects that low-cost Chinese humanoids will pressure the European collaborative robot industry, currently concentrated among ABB, Kuka, and Universal Robots, by at least 15% price erosion over the next two years.

What the CIO Needs to Observe

Global manufacturing procurement and operations teams need to map three fronts. First, the timing of entry: a Unitree humanoid in an industrial pilot today costs 3% of what an Atlas would have cost three years ago, making the return cycle measurable within a normal budget window. Second, the export risk: if the Entity List expands, a contract in RMB signed this quarter could turn into a compliance headache by 2027. Third, the connection with DeepSeek: if embedded models are restricted by sanctions, Unitree hardware loses part of its functional advantage.

The takeaway is this: for the first time, an entire public market must price a humanoid backed by a Chinese brand. This changes the mathematics of any boardroom that considers industrial robotics as a future challenge.